156 related articles for article (PubMed ID: 21530486)
21. Hysteresis of butyrylcholinesterase in the approach to steady-state kinetics.
Masson P; Schopfer LM; Froment MT; Debouzy JC; Nachon F; Gillon E; Lockridge O; Hrabovska A; Goldstein BN
Chem Biol Interact; 2005 Dec; 157-158():143-52. PubMed ID: 16256969
[TBL] [Abstract][Full Text] [Related]
22. Effects of Ni(2+), Co(2+), and Mn(2+) on desensitized butyrylcholinesterase prepared from human serum.
Cengiz D; Cokugras AN; Tezcan EF
Biol Trace Elem Res; 2003; 93(1-3):55-62. PubMed ID: 12835490
[TBL] [Abstract][Full Text] [Related]
23. Reversible inhibition of acetylcholinesterase and butyrylcholinesterase by 4,4'-bipyridine and by a coumarin derivative.
Simeon-Rudolf V; Kovarik Z; Radić Z; Reiner E
Chem Biol Interact; 1999 May; 119-120():119-28. PubMed ID: 10421445
[TBL] [Abstract][Full Text] [Related]
24. An assessment of the role of intracellular reductive capacity in the biological clearance of triarylmethane dyes.
Tacal O; Ozer I
J Hazard Mater; 2007 Oct; 149(2):518-22. PubMed ID: 17869415
[TBL] [Abstract][Full Text] [Related]
25. Inhibition of two different cholinesterases by tacrine.
Ahmed M; Rocha JB; Corrêa M; Mazzanti CM; Zanin RF; Morsch AL; Morsch VM; Schetinger MR
Chem Biol Interact; 2006 Aug; 162(2):165-71. PubMed ID: 16860785
[TBL] [Abstract][Full Text] [Related]
26. Tetramerization domain of human butyrylcholinesterase is at the C-terminus.
Blong RM; Bedows E; Lockridge O
Biochem J; 1997 Nov; 327 ( Pt 3)(Pt 3):747-57. PubMed ID: 9581552
[TBL] [Abstract][Full Text] [Related]
27. Differences in active site gorge dimensions of cholinesterases revealed by binding of inhibitors to human butyrylcholinesterase.
Saxena A; Redman AM; Jiang X; Lockridge O; Doctor BP
Biochemistry; 1997 Dec; 36(48):14642-51. PubMed ID: 9398183
[TBL] [Abstract][Full Text] [Related]
28. Structural aspects of flavonoids as inhibitors of human butyrylcholinesterase.
Katalinić M; Rusak G; Domaćinović Barović J; Sinko G; Jelić D; Antolović R; Kovarik Z
Eur J Med Chem; 2010 Jan; 45(1):186-92. PubMed ID: 19879672
[TBL] [Abstract][Full Text] [Related]
29. Asymmetric fluorogenic organophosphates for the development of active organophosphate hydrolases with reversed stereoselectivity.
Amitai G; Adani R; Yacov G; Yishay S; Teitlboim S; Tveria L; Limanovich O; Kushnir M; Meshulam H
Toxicology; 2007 Apr; 233(1-3):187-98. PubMed ID: 17129656
[TBL] [Abstract][Full Text] [Related]
30. Adenovirus-transduced human butyrylcholinesterase in mouse blood functions as a bioscavenger of chemical warfare nerve agents.
Chilukuri N; Duysen EG; Parikh K; diTargiani R; Doctor BP; Lockridge O; Saxena A
Mol Pharmacol; 2009 Sep; 76(3):612-7. PubMed ID: 19542320
[TBL] [Abstract][Full Text] [Related]
31. A single amino acid substitution, Gly117His, confers phosphotriesterase (organophosphorus acid anhydride hydrolase) activity on human butyrylcholinesterase.
Lockridge O; Blong RM; Masson P; Froment MT; Millard CB; Broomfield CA
Biochemistry; 1997 Jan; 36(4):786-95. PubMed ID: 9020776
[TBL] [Abstract][Full Text] [Related]
32. DNA sequence of butyrylcholinesterase from the rat: expression of the protein and characterization of the properties of rat butyrylcholinesterase.
Boeck AT; Schopfer LM; Lockridge O
Biochem Pharmacol; 2002 Jun; 63(12):2101-10. PubMed ID: 12110369
[TBL] [Abstract][Full Text] [Related]
33. Aging of di-isopropyl-phosphorylated human butyrylcholinesterase.
Masson P; Fortier PL; Albaret C; Froment MT; Bartels CF; Lockridge O
Biochem J; 1997 Oct; 327 ( Pt 2)(Pt 2):601-7. PubMed ID: 9359435
[TBL] [Abstract][Full Text] [Related]
34. Rate-determining step of butyrylcholinesterase-catalyzed hydrolysis of benzoylcholine and benzoylthiocholine. Volumetric study of wild-type and D70G mutant behavior.
Masson P; Bec N; Froment MT; Nachon F; Balny C; Lockridge O; Schopfer LM
Eur J Biochem; 2004 May; 271(10):1980-90. PubMed ID: 15128307
[TBL] [Abstract][Full Text] [Related]
35. Effects of viscosity and osmotic stress on the reaction of human butyrylcholinesterase with cresyl saligenin phosphate, a toxicant related to aerotoxic syndrome: kinetic and molecular dynamics studies.
Masson P; Lushchekina S; Schopfer LM; Lockridge O
Biochem J; 2013 Sep; 454(3):387-99. PubMed ID: 23782236
[TBL] [Abstract][Full Text] [Related]
36. Polyionic complexes of butyrylcholinesterase and poly-l-lysine-g-poly(ethylene glycol): Comparative kinetics of catalysis and inhibition and in vitro inactivation by proteases and heat.
Hester K; Liu J; Flynn N; Sultatos LG; Geng L; Brimijoin S; Ramsey JD; Hartson S; Ranjan A; Pope C
Chem Biol Interact; 2017 Sep; 275():86-94. PubMed ID: 28756151
[TBL] [Abstract][Full Text] [Related]
37. Catalytic activities of a cocaine hydrolase engineered from human butyrylcholinesterase against (+)- and (-)-cocaine.
Xue L; Hou S; Yang W; Fang L; Zheng F; Zhan CG
Chem Biol Interact; 2013 Mar; 203(1):57-62. PubMed ID: 22917637
[TBL] [Abstract][Full Text] [Related]
38. A single amino acid substitution in the human and a bacterial hypoxanthine phosphoribosyltransferase modulates specificity for the binding of guanine.
Lee CC; Craig SP; Eakin AE
Biochemistry; 1998 Mar; 37(10):3491-8. PubMed ID: 9521670
[TBL] [Abstract][Full Text] [Related]
39. Preparation and in vitro screening of symmetrical bispyridinium cholinesterase inhibitors bearing different connecting linkage-initial study for Myasthenia gravis implications.
Musilek K; Komloova M; Zavadova V; Holas O; Hrabinova M; Pohanka M; Dohnal V; Nachon F; Dolezal M; Kuca K; Jung YS
Bioorg Med Chem Lett; 2010 Mar; 20(5):1763-6. PubMed ID: 20138518
[TBL] [Abstract][Full Text] [Related]
40. Aging pathways for organophosphate-inhibited human butyrylcholinesterase, including novel pathways for isomalathion, resolved by mass spectrometry.
Li H; Schopfer LM; Nachon F; Froment MT; Masson P; Lockridge O
Toxicol Sci; 2007 Nov; 100(1):136-45. PubMed ID: 17698511
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
